Pfizer (PFE) to Discontinue Bococizumab Development Program; Sees EPS Impact
Go back to Pfizer (PFE) to Discontinue Bococizumab Development Program; Sees EPS Impact| PANDORA MEDIA, Inc. (NYSE: P) | Delayed: 74.61 +1.94 (2.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $72.67 | 52 Week High | $16.23 | |||
| Open | $74.22 | 52 Week Low | $7.10 | |||
| Day High | $74.78 | P/E | N/A | |||
| Day Low | $72.21 | EPS | $-0.15 | |||
| Volume | 7,522,874 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 25.21 -0.71 (2.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.92 | 52 Week High | $37.39 | |||
| Open | $25.58 | 52 Week Low | $28.25 | |||
| Day High | $25.36 | P/E | 15.28 | |||
| Day Low | $24.94 | EPS | $1.65 | |||
| Volume | 119,614,341 | |||||
